SENORES PHARMACEUTICALS L (SENORES) — Cash Flow Reinvestment Rate

Latest as of September 2025: 3.99x

SENORES PHARMACEUTICALS L (SENORES) has a Cash Flow Reinvestment Rate of 3.99x as of September 2025, reinvesting Rs966.90 Million (capex Rs966.90 Million ) from operating cash flow of Rs242.20 Million. See SENORES FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

3.99x

(Capex + Investments) / Operating CF

Total Reinvested

Rs966.90 Million

Capex + Investments

Operating Cash Flow

Rs242.20 Million

INR

Capital Expenditures

Rs966.90 Million

INR

SENORES PHARMACEUTICALS L Cash Flow Reinvestment Rate (2026–2026)

Historical reinvestment intensity for SENORES PHARMACEUTICALS L across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of SENORES PHARMACEUTICALS L.

Annual Cash Flow Reinvestment Rate for SENORES PHARMACEUTICALS L (2026–2026)

Year-by-year capital reinvestment analysis for SENORES PHARMACEUTICALS L. See SENORES PHARMACEUTICALS L free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year	Reinvestment Rate	Total Reinvested (INR)	Operating CF	Capex	YoY Change
2026	6.87x	Rs4.27 Billion	Rs620.50 Million	Rs2.65 Billion	—

Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow